72 related articles for article (PubMed ID: 15244102)
1. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: a 2-year randomized trial.
Mellberg C; Sandberg S; Ryberg M; Eriksson M; Brage S; Larsson C; Olsson T; Lindahl B
Eur J Clin Nutr; 2014 Mar; 68(3):350-7. PubMed ID: 24473459
[TBL] [Abstract][Full Text] [Related]
2. Prediction of weight loss and regain following dietary, lifestyle, and pharmacologic intervention.
Napolitano A; Miller SR; Murgatroyd PR; Delafont B; Brooke A; Elkhawad M; Tan CY; Virtue S; Vidal-Puig A; Nunez DJ
Clin Pharmacol Ther; 2012 Jun; 91(6):1027-34. PubMed ID: 22336590
[TBL] [Abstract][Full Text] [Related]
3. The perils of pharmacological treatment for obesity: a case of sibutramine-associated cardiomyopathy and malignant arrhythmias.
Schamroth CL
Cardiovasc J Afr; 2012 Mar; 23(2):e11-2. PubMed ID: 22447507
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment for obesity. We need more studies in men at higher risk of coronary events.
Després JP
BMJ; 2001 Jun; 322(7299):1379-80. PubMed ID: 11397730
[No Abstract] [Full Text] [Related]
5. Dishonesty is more affected by BMI status than by short-term changes in glucose.
Polizzi di Sorrentino E; Herrmann B; Villeval MC
Sci Rep; 2020 Jul; 10(1):12170. PubMed ID: 32699212
[TBL] [Abstract][Full Text] [Related]
6. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
7. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
Van Gaal LF; Wauters MA; De Leeuw IH
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk-benefit profile of sibutramine.
Scheen AJ
Am J Cardiovasc Drugs; 2010; 10(5):321-34. PubMed ID: 20860415
[TBL] [Abstract][Full Text] [Related]
9. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
Sabuncu T; Ucar E; Birden F; Yasar O
Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
[TBL] [Abstract][Full Text] [Related]
10. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
11. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
[TBL] [Abstract][Full Text] [Related]
12. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
[TBL] [Abstract][Full Text] [Related]
13. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
